Blood Testing System and Method
A patent family: one line of work, grouped by real continuity rather than by a technology label
inferred from titles. 3 of these applications claim priority to application 14/500,248, filed Sep 29, 2014. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
| Patent | Title | Holder | Status | Expires | Time remaining | Confidence |
|---|---|---|---|---|---|---|
| US 11,327,069 | Blood Testing System and Method In force · High confidence | CA Casyso GmbH | In force | High confidence | ||
| US 11,719,688 | Blood Testing System and Method In force · High confidence | CA Casyso GmbH | In force | High confidence | ||
| US 10,175,225 | Blood Testing System and Method In force · High confidence | C a Casyso AG | In force | High confidence | ||
| US 12,578,349 | Blood Testing System and Method In force · Medium confidence | C a Casyso GmbH | In force | Medium confidence | ||
| Application 18/213,388 | Blood Testing System and Method Pending Not granted | C A Casyso GmbH | Pending | Not granted | not computed |
5 of 5 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
4 of these are in force and held by CA, Inc..
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.